iBio, Inc.
IBIO$84M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEW YORK
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Sep 4, 2026
13dMarket Overview
Stock performance and key metrics
IBIO News
Catalyst Timeline
1 upcoming, 0 past
EarningsNext
IBIO Earnings Report
Sep 4, 2026Confirmed
EPS Est: $-0.07 | FQ end 2026-06
How IBIO's past catalysts played out
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is iBio, Inc.'s next FDA catalyst?→
iBio, Inc.'s (IBIO) next tracked catalyst is a Earnings expected September 4, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track IBIO biotech catalysts?→
Add IBIO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow iBio, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply